Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -16.259% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) COC(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc2c(c1)n(C)c(=O)c(=O)n2C
(b) Cc1c(OC(C)C(=O)NCc2cccnc2)ccc2c3c(c(=O)oc12)CCCC3
(c) CCCCN(C(=O)c1ccc(COc2ccccc2)o1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
Answer: b. Cc1c(OC(C)C(=O)NCc2cccnc2)ccc2c3c(c(=O)oc12)CCCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(OC(C)C(=O)NCc2cccnc2)ccc2c3c(c(=O)oc12)CCCC3
Cc1c(OC(C)C(=O)NCc2cccnc2)ccc2c3c(c(=O)oc12)CCCC3
2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]-N-(pyridin-3-ylmethyl)propanamide